Clinical Trial Update: Azacitidine and Etanercept in Treating Patients With Myelodysplastic Syndromes [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update reports results for the combination of azacitidine and etanercept in patients with myelodysplastic syndromes, including de nov…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Azacitidine (Vidaza) (azacitidine)
• Etanercept (Enbrel) (Etanercept)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-05-24